Laboratory Corporation of America Holdings – NYSE:LH
Laboratory Corporation of America Holdings stock price today
$275.78
+45.34
+19.68%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
Laboratory Corporation of America Holdings stock price monthly change
+11.77%
month
Laboratory Corporation of America Holdings stock price quarterly change
+11.77%
quarter
Laboratory Corporation of America Holdings stock price yearly change
+1.66%
year
Laboratory Corporation of America Holdings key metrics
Market Cap | 18.98B |
Enterprise value | 25.47B |
P/E | 44.44 |
EV/Sales | 2.00 |
EV/EBITDA | 18.00 |
Price/Sales | 1.51 |
Price/Book | 2.36 |
PEG ratio | 18.81 |
EPS | 4.99 |
Revenue | 12.30B |
EBITDA | 1.70B |
Income | 433.1M |
Revenue Q/Q | -15.91% |
Revenue Y/Y | -16.63% |
Profit margin | 3.43% |
Oper. margin | 8.8% |
Gross margin | 26.49% |
EBIT margin | 8.8% |
EBITDA margin | 13.88% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLaboratory Corporation of America Holdings stock price history
Laboratory Corporation of America Holdings stock forecast
Laboratory Corporation of America Holdings financial statements
| Jun 2023 | 3.03B | 188.9M | 6.23% |
|---|---|---|---|
| Sep 2023 | 3.05B | 183.3M | 6% |
| Dec 2023 | 3.03B | -167.1M | -5.51% |
| Mar 2024 | 3.17B | 228M | 7.18% |
| Sep 2025 | 3.37B | 353.14M | 10.47% |
|---|---|---|---|
| Oct 2025 | 3.42B | 344.61M | 10.07% |
| Dec 2025 | 3.39B | 333.47M | 9.82% |
| Mar 2026 | 3.40B | 367.85M | 10.81% |
Analysts Price target
Financials & Ratios estimates
1.56%
Yield TTM
| Payout ratio | 56.05% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | 1.06% |
| 2023 | 1.28% |
| Jun 2023 | 17705700000 | 8.91B | 50.34% |
|---|---|---|---|
| Sep 2023 | 16886000000 | 8.99B | 53.26% |
| Dec 2023 | 16725099999 | 8.83B | 52.82% |
| Mar 2024 | 16531000000 | 8.55B | 51.76% |
| Jun 2023 | 351.4M | -253.6M | 1.54B |
|---|---|---|---|
| Sep 2023 | 275.5M | -487.6M | -987.8M |
| Dec 2023 | 579.6M | -330.6M | -446.5M |
| Mar 2024 | -29.8M | -393.1M | -11.7M |
Laboratory Corporation of America Holdings alternative data
What is mobile apps rank?
Labcorp | Patient
| Platform: | Android |
| Store: | Google Play  |
| Type: | Free |
| Market: | United States |
Category:
| Aug 2023 | 33 |
|---|---|
| Sep 2023 | 23 |
| Oct 2023 | 31 |
| Nov 2023 | 46 |
| Dec 2023 | 48 |
| Jan 2024 | 37 |
| Feb 2024 | 35 |
| Mar 2024 | 25 |
| Apr 2024 | 23 |
| May 2024 | 33 |
| Jun 2024 | 24 |
| Jul 2024 | 33 |
| Aug 2024 | 25 |
| Sep 2024 | 23 |
| Oct 2024 | 25 |
| Nov 2024 | 23 |
| Dec 2024 | 48 |
Category:
| Aug 2023 | 29 |
|---|---|
| Sep 2023 | 27 |
| Oct 2023 | 32 |
| Nov 2023 | 30 |
| Dec 2023 | 40 |
| Jan 2024 | 29 |
| Feb 2024 | 28 |
| Mar 2024 | 26 |
| Apr 2024 | 29 |
| May 2024 | 21 |
| Jun 2024 | 26 |
| Jul 2024 | 15 |
| Aug 2024 | 21 |
| Sep 2024 | 26 |
| Oct 2024 | 23 |
| Nov 2024 | 19 |
| Dec 2024 | 38 |
Laboratory Corporation of America Holdings Social Media Accounts
What are followers?
+1.90%
month
+19.13%
quarter
| Aug 2023 | 13189 |
|---|---|
| Sep 2023 | 13439 |
+1.98%
month
| May 2025 | 12461 |
|---|---|
| Jul 2025 | 13200 |
| Aug 2025 | 13462 |
What is job openings count?
| Aug 2023 | 1,826 |
|---|---|
| Sep 2023 | 1,344 |
| Oct 2023 | 1,644 |
| Nov 2023 | 1,754 |
| Dec 2023 | 1,895 |
| Jan 2024 | 1,887 |
| Feb 2024 | 1,981 |
| Apr 2024 | 1,489 |
| May 2024 | 1,905 |
| Jun 2024 | 1,505 |
| Jul 2024 | 1,624 |
| Aug 2023 | 70,400 |
|---|---|
| Sep 2023 | 60,000 |
| Oct 2023 | 60,000 |
| Nov 2023 | 60,000 |
| Dec 2023 | 60,000 |
| Jan 2024 | 60,000 |
| Feb 2024 | 60,000 |
| Mar 2024 | 56,950 |
| Apr 2024 | 56,950 |
| May 2024 | 67,000 |
| Jun 2024 | 67,000 |
| Jul 2024 | 67,000 |
Laboratory Corporation of America Holdings other data
83.07%
-3.41%
of LH is owned by hedge funds
1.00K
-40
80.99M
-2.97M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 35693 |
| Mar 2024 | 0 | 8828 |
| Apr 2024 | 0 | 12666 |
| May 2024 | 0 | 2250 |
| Aug 2024 | 0 | 30093 |
| Oct 2024 | 0 | 1000 |
| Nov 2024 | 0 | 10860 |
| Dec 2024 | 0 | 12711 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | EISENBERG GLENN A officer: Executiv.. | Common Stock | 2,788 | $221.67 | $618,016 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Common Stock | 2,788 | $221.67 | $618,016 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Common Stock | 8,923 | $209.25 | $1,867,138 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Common Stock | 8,923 | $209.25 | $1,867,138 | ||
Sale | EISENBERG GLENN A officer: Executiv.. | Common Stock | 11,711 | $240.43 | $2,815,652 | ||
Sale | EISENBERG GLENN A officer: Executiv.. | Common Stock | 11,711 | $240.43 | $2,815,652 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Non-qualified Stock Options | 2,788 | $221.67 | $618,016 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Non-qualified Stock Options | 2,788 | $221.67 | $618,016 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Non-qualified Stock Options | 8,923 | $209.25 | $1,867,138 | ||
Option | EISENBERG GLENN A officer: Executiv.. | Non-qualified Stock Options | 8,923 | $209.25 | $1,867,138 |
| Patent |
|---|
Grant Filling date: 5 Sep 2019 Issue date: 6 Sep 2022 |
Grant Filling date: 30 Oct 2019 Issue date: 30 Aug 2022 |
Application Filling date: 4 Feb 2022 Issue date: 4 Aug 2022 |
Grant Utility: Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients Filling date: 22 Oct 2018 Issue date: 2 Aug 2022 |
Grant Filling date: 18 Oct 2018 Issue date: 2 Aug 2022 |
Application Filling date: 14 Jan 2022 Issue date: 21 Jul 2022 |
Application Clinical Laboratory-Based Disease Management Program, With Automated Patient-Specific Treatment Advice Filling date: 2 Nov 2021 Issue date: 21 Jul 2022 |
Application Filling date: 23 Nov 2021 Issue date: 7 Jul 2022 |
Application DATABASE REDUCTION BASED ON GEOGRAPHICALLY CLUSTERED DATA TO PROVIDE RECORD SELECTION FOR CLINICAL TRIALS Filling date: 7 Apr 2020 Issue date: 30 Jun 2022 |
Grant Utility: Sample receiving system and methods Filling date: 31 Jan 2019 Issue date: 28 Jun 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 25 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 26 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Adam H. Schechter (1965) Pres, Chief Executive Officer & Chairman | $4,870,000 |
| Mr. Glenn A. Eisenberg (1961) Chief Financial Officer & Executive Vice President | $1,980,000 |
| Dr. Paul R. Kirchgraber M.D. (1962) Executive Vice President & Chief Executive Officer of Covance Drug Devel. | $1,400,000 |
| Mr. Mark S. Schroeder (1961) Executive Vice President and Pres of Diagnostics Laboratory Operations & Global Supply Chain | $1,400,000 |
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH (1974) Executive Vice President, Pres of Diagnostics & Chief Medical Officer | $1,370,000 |
Fortrea Holdings: Many Questions Post The Spin-Off
Capitalizing On Inflammation's Role In Neurological Disease Part 1: Coya Therapeutics
Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Fortrea: A Strong Hold Following The Spin-Off
Laboratory Corporation: Predictability Of Cash Flows Less Visible
ProPhase Labs: Lots Of Moving Pieces
Fulgent Genetics: Surviving The Covid Cliff
Laboratory Corporation: Plenty Of Growth Runway
CVS Health: Acquisitions May Not Create True Value
-
What's the price of Laboratory Corporation of America Holdings stock today?
One share of Laboratory Corporation of America Holdings stock can currently be purchased for approximately $275.78.
-
When is Laboratory Corporation of America Holdings's next earnings date?
Unfortunately, Laboratory Corporation of America Holdings's (LH) next earnings date is currently unknown.
-
Does Laboratory Corporation of America Holdings pay dividends?
Yes, Laboratory Corporation of America Holdings pays dividends and its trailing 12-month yield is 1.56% with 56% payout ratio. The last Laboratory Corporation of America Holdings stock dividend of $0.08 was paid on 26 Apr 1994.
-
How much money does Laboratory Corporation of America Holdings make?
Laboratory Corporation of America Holdings has a market capitalization of 18.98B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.25% to 12.16B US dollars.
-
What is Laboratory Corporation of America Holdings's stock symbol?
Laboratory Corporation of America Holdings is traded on the NYSE under the ticker symbol "LH".
-
What is Laboratory Corporation of America Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Laboratory Corporation of America Holdings?
Shares of Laboratory Corporation of America Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Laboratory Corporation of America Holdings's key executives?
Laboratory Corporation of America Holdings's management team includes the following people:
- Mr. Adam H. Schechter Pres, Chief Executive Officer & Chairman(age: 60, pay: $4,870,000)
- Mr. Glenn A. Eisenberg Chief Financial Officer & Executive Vice President(age: 64, pay: $1,980,000)
- Dr. Paul R. Kirchgraber M.D. Executive Vice President & Chief Executive Officer of Covance Drug Devel.(age: 63, pay: $1,400,000)
- Mr. Mark S. Schroeder Executive Vice President and Pres of Diagnostics Laboratory Operations & Global Supply Chain(age: 64, pay: $1,400,000)
- Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH Executive Vice President, Pres of Diagnostics & Chief Medical Officer(age: 51, pay: $1,370,000)
-
How many employees does Laboratory Corporation of America Holdings have?
As Jul 2024, Laboratory Corporation of America Holdings employs 67,000 workers, which is 18% more then previous quarter.
-
When Laboratory Corporation of America Holdings went public?
Laboratory Corporation of America Holdings is publicly traded company for more then 35 years since IPO on 29 Mar 1990.
-
What is Laboratory Corporation of America Holdings's official website?
The official website for Laboratory Corporation of America Holdings is labcorp.com.
-
Where are Laboratory Corporation of America Holdings's headquarters?
Laboratory Corporation of America Holdings is headquartered at 358 South Main Street, Burlington, NC.
-
How can i contact Laboratory Corporation of America Holdings?
Laboratory Corporation of America Holdings's mailing address is 358 South Main Street, Burlington, NC and company can be reached via phone at +33 62291127.
Laboratory Corporation of America Holdings company profile:
Laboratory Corporation of America Holdings
labcorp.comExchange:
NYSE
Full time employees:
67,000
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
358 South Main Street
Burlington, NC 27215
Burlington, NC 27215
CIK: 0000920148
ISIN: US50540R4092
CUSIP: 50540R409
